Massachusetts Financial Services Co. MA Acquires Shares of 100,823 Owens & Minor, Inc. (NYSE:OMI)

Massachusetts Financial Services Co. MA acquired a new position in shares of Owens & Minor, Inc. (NYSE:OMI - Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 100,823 shares of the company's stock, valued at approximately $1,582,000. Massachusetts Financial Services Co. MA owned approximately 0.13% of Owens & Minor as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of OMI. Foundry Partners LLC bought a new position in shares of Owens & Minor during the 3rd quarter worth approximately $5,238,000. Intech Investment Management LLC grew its position in Owens & Minor by 102.0% in the third quarter. Intech Investment Management LLC now owns 45,655 shares of the company's stock valued at $716,000 after purchasing an additional 23,055 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. grew its position in Owens & Minor by 374.2% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 223,074 shares of the company's stock valued at $3,500,000 after purchasing an additional 176,029 shares in the last quarter. Segall Bryant & Hamill LLC increased its stake in Owens & Minor by 2.1% in the 3rd quarter. Segall Bryant & Hamill LLC now owns 137,199 shares of the company's stock valued at $2,153,000 after buying an additional 2,883 shares during the last quarter. Finally, Meeder Asset Management Inc. lifted its position in Owens & Minor by 844.1% during the 3rd quarter. Meeder Asset Management Inc. now owns 9,016 shares of the company's stock worth $141,000 after buying an additional 8,061 shares in the last quarter. Institutional investors and hedge funds own 98.04% of the company's stock.

Insider Buying and Selling at Owens & Minor

In other news, CFO Jonathan A. Leon sold 5,282 shares of the company's stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $11.82, for a total transaction of $62,433.24. Following the completion of the sale, the chief financial officer now directly owns 130,822 shares in the company, valued at approximately $1,546,316.04. This represents a 3.88 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 3.59% of the company's stock.

Owens & Minor Stock Performance

OMI stock traded up $0.12 during mid-day trading on Thursday, hitting $13.31. 354,495 shares of the company were exchanged, compared to its average volume of 822,167. Owens & Minor, Inc. has a 1-year low of $11.42 and a 1-year high of $28.35. The business has a 50 day simple moving average of $13.60 and a 200-day simple moving average of $15.08. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11. The stock has a market capitalization of $1.03 billion, a PE ratio of -20.48, a price-to-earnings-growth ratio of 0.47 and a beta of 0.41.

Owens & Minor (NYSE:OMI - Get Free Report) last issued its quarterly earnings data on Monday, November 4th. The company reported $0.42 EPS for the quarter, beating analysts' consensus estimates of $0.41 by $0.01. The firm had revenue of $2.72 billion for the quarter, compared to analyst estimates of $2.68 billion. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The company's revenue for the quarter was up 5.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.44 EPS. On average, equities analysts forecast that Owens & Minor, Inc. will post 1.49 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on OMI. UBS Group decreased their price objective on Owens & Minor from $28.00 to $25.00 and set a "buy" rating for the company in a report on Tuesday, November 5th. Barclays lowered their price target on Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating on the stock in a research report on Tuesday, November 5th. Citigroup cut their price objective on Owens & Minor from $21.00 to $18.50 and set a "buy" rating for the company in a report on Tuesday, November 5th. StockNews.com downgraded shares of Owens & Minor from a "buy" rating to a "hold" rating in a report on Monday, August 26th. Finally, Robert W. Baird cut their price target on shares of Owens & Minor from $19.00 to $14.00 and set a "neutral" rating for the company in a research note on Tuesday, November 5th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $18.50.

Owens & Minor Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.